# A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)

> **NCT00092300** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 450 (—)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** MK0966, rofecoxib
- **DRUG:** Comparator: valdecoxib

## Key facts

- **NCT ID:** NCT00092300
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2002-09
- **Final completion:** —
- **Target enrollment:** 450 (—)
- **Last updated:** 2015-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092300, "A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT00092300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*